-- Data to be presented from CORAL-BOOST and CORAL-CEPI trials evaluating Gritstone’s samRNA vaccine candidates against SARS-CoV-2 -- EMERYVILLE, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most…
A novel vascularized skin-equivalent was constructed to study immune responses and drug efficacy during HSV infection.
Functional genetic screen identifies RAS synthetic lethal kinases in squamous cell carcinoma model
Cellular ACE2 expression level is an important variable in determining which antibodies can neutralize SARS-CoV-2 in laboratory assays
Financial worry: medical care, lifestyle, and basic needs
Bloom Lab finds that the influenza-infected cells that produce the most viral RNA do not produce the most viral progeny.
Interrogation of DNA methylation profiles from esophageal brushing samples enables early detection of esophageal adenocarcinoma and high-grade dysplasia.
CAR-T cell therapy targeting oncogenic fusion CBF/GLIS driven pediatric cancer successfully reduces disease burden in in vitro and in vivo models.
From the Salama Lab, Human Biology, Public Health Sciences, and Basic Sciences Divisions
Microtubule integrity regulates gene expression programs that prevent premature cell division via transcriptional and translational control
Bomedemstat and anti-PD1 immunotherapy are stronger together than separately when it comes to fighting small cell lung cancer.
A Fred Hutchinson Cancer Center team has developed a strategy that could improve the effects of bone marrow transplantation for blood cancer while minimizing GHVD. Laboratory models of leukemia and multiple myeloma showed that clearing away GVHD-causing immune cells before boosting cancer-attacking…
Investigators of an expanded clinical trial have administered an investigational CAR-T cell therapy to the first patient with blood cancer.
“Doc, should I cancel my colonoscopy?” To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.Login Subscrib…
Computational biologist Dr. Anat Zimmer, a post-doctoral researcher in Dr. Gavin Ha’s lab at Fred Hutchinson Cancer Center, was awarded a 2022-23 fellowship by the American Association of University Women.
Fred Hutchinson Cancer Center on Wednesday announced an enormous philanthropic gift of $710.5 million from Jackie and Mike Bezos, the parents of Amazon founder Jeff Bezos, pledged on behalf of… Read More
Storyteller, artist and Lower Elwha S’Klallam Tribe member Roger Fernandes was selected as the featured Indigenous artist in Fred Hutch’s Public Art and Community Dialogue Program. His art was unveiled Monday at an on-campus event.
The phase 1/2 clinical trial of MB-106 is demonstrating high efficacy, durable responses, and a favorable safety profile as the first patient treated did not experience cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome
Almost two years after securing its third drug approval, Alnylam is touting an expanded label for Oxlumo. The company put out word on Thursday night that the FDA approved an sNDA for its treatment lumasiran for primary hyperoxaluria type 1, also known as Ph1. The rare genetic disease, in which the
Only a few months after expanding its facility in Holly Springs, NC, vaccine maker CSL Seqirus is putting the new location to use with its latest contract. HHS’s BARDA has chosen CSL Seqirus to produce an H5N8 A/Astrakhan virus vaccine candidate for a Phase II study which is slated to